by Dr. Yashashwini Reddy | Sep 24, 2025
Case Study: Gilead’s Remdesivir during COVID-19 Pandemic Background Remdesivir is an antiviral originally developed by Gilead Sciences for Ebola virus infection. During the COVID-19 pandemic (2020), early in-vitro and clinical data suggested that Remdesivir could...
by Dr. Yashashwini Reddy | Jun 14, 2024
Global expedited regulatory pathways are processes crafted to speed up new drug approval and availability across different countries. These include drugs, vaccines, and medical devices. These pathways aim to bring the new drugs as fast as possible by fastening the...
